1 / 22

Vascular Analysis of Disease

Vascular Analysis of Disease. In Nuclear Medicine. Blood Flow to the Extremities. Consider chronic or acute disease Blood flow interruption from arterial occlusions Embolism, thrombus, or a vascular injury

wtalley
Download Presentation

Vascular Analysis of Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vascular Analysis of Disease In Nuclear Medicine

  2. Blood Flow to the Extremities • Consider chronic or acute disease • Blood flow interruption from arterial occlusions • Embolism, thrombus, or a vascular injury • Most procedures analyze venous blood flow and physiological uptake of the radiotracer • However, given certain situations arterial evaluation should be considered

  3. Clinically Speaking • Regional distribution of vascular flow can be done using stress and rest procedures – Sound familiar? • Graft patency via blood flow determine viability • Evaluation of: ischemic ulcers and pre-amputation • AV malformation, shunts, vascular tumors, embolization • Venous evaluation of infection and DVTs • Angiography issue is its failure to evaluate collateral circulation • Is there collateral circulation that contrast files to image • Post injection contrast does not evaluate physiology

  4. Xenon Utilization Purpose – To evaluate blood flow in muscle tissue • Think of 133Xe and its imaging characteristics • 0.1 mL saline with 100 μCi 133Xe injected IM 1 to 2 cm into muscle • Needle is not removed for 30 seconds, but images or data is collected in a serial mode • Declining activity is quantified with semilog paper • Procedure is done twice: stress and rest Lower extremities • Normal - 2 (rest) and 50 (stress) mL/min/100g • Abnormal - <20 (stress) mL/min/100g

  5. Arterial Evaluation • Siegel el al. injected 99mTcHAM into the descending aorta or femoral artery • Rest and stress images taken in the extremities • Compared with contrast angiography • Disease was confirmed in both: large vessel occlusion, small vessel disease, ischemic ulcers, and other • Test is rarely done with arterial injection because of its invasive nature

  6. Diffusible Tracer • While a patient underwent 201Tl in cardiology whole body scans were performed to evaluate muscle distribution of the tracer • Segall et al. noted stress and redistribution images in the legs with peripheral vascular disease • Normal patients: Leg activity = 25% of the total dose with stress having a greater amount than rest • Abnormal – Rest imaging in the leg had higher levels of activity when compared with stress indicating disease

  7. Types of Vascular Evaluation • Determining the level or area of amputation based on ischemic areas in an extremity • mL/min/100g evaluated at three points using 133Xe: above the knee, below the knee, and the foot • Evaluate the pedicle flaps in reconstructive surgery • mL/min/100g used with 133Xe and 99mTcO4- • If a probe recorded delayed clearance, graft was not viable • Determine treatment of skin ulcers • Similar - mL/min/100g analysis used

  8. Frost Bite and Electrical Burns Frost Bite • 99mTcO4- used to evaluate viable from non-viable tissue in the finger and toes. Lack of activity indicated loss of blood flow Electrical Burns • Using 99mTcPYP extent of muscle damage can be determined • Lacking uptake and flow was an indication of necrotic tissue • Delayed images also showed a donut shapes (cold center) and focal hotspots indicating damaged viable to the tissue

  9. Monitoring Therapeutic Embolization • Polyvinyl alcohol spongelike (Ivalon) particles are used to occlude AV malformation and vascular tumors • Particles are tagged with 99mTcsulfur colloid so that the procedure can be monitored for its effectiveness • Catheter inserted and placed at the site of interest where embolization occurs • If too Ivalon particles appear in the lung “PE” type issues occur, requiring catheter adjustment

  10. Repair of an Aneurysm • 99mTcRBCs are injected IV to identify an aneurysm. • Green arrows indicate aneurysm • Purple indicate repair • Note the difference in radiopharmaceutical distribution

  11. Diagnosis of DVTs • Contrast venography (gold standard) – 100 mL contrast injected into the dorsal vein in the foot • DVT is diagnosed when flow abruptly stops or lack of deep vein filling occurs • Impedance Plethysmography (IPG) – Using an inflated thigh cuff, blood flow impedance is measure • Releasing cuff pressure and the lack reduced venous pressure via its electrical impedance is an indication of DTV

  12. Diagnosing DVT (cont.) Ultrasound • Color Doppler with compression technique is used to detect DVT • Color separates venous (blue) from arterial (red) • Compression without the vein compressing indicates DVT

  13. DVT/NMT Procedure • Most common radiopharmaceutical is 99mTcMAA where bilateral IV is setup, one for each foot • 1 – 2 mCi are injected at the same time with serial imaging • Alternative approach – tourniquet is applied at different points on the leg and a set of injections with serial images are taken • Detector placement must done at different intervals • Tib/fib, knees, and thigh • Depends on the size of the detector

  14. Biodistribution of the Particles • Electrostatic forces between MAA and DVT cause the particles to stick to the DVT • Perfusion lung can now follow this procedure • What happens when you flush your syringe when injecting for a perfusion lung scan?

  15. AcuTect: General Information • Used to diagnosis DVT • A synthetic peptide (not a MoAb!) - Apcitide • Binds to glycoprotein GP IIb/IIIa • platelet receive signals that cause activation and aggregation of the thrombus • Aggregation depended on GP IIb/IIIa receptor • AcutTect binds adhesion-molecule receptors found in the accute DVT • Was quickly approved by the FDA • Produced by Diatide, Incorporated and distributed by Nycomed Amersham

  16. AcuTect: Clinical Trails(General) • Two clinical trials where completed on patients suspected of having DVT • Study A = 136 patients • Study B = 145 patients • All patients where analyzed with AcutTect and Contrast Venography • Total of 236 patients where finally processed

  17. AcuTect: Clinical Trails - NMT Results • Independently evaluated by NM physicians • Data collected at 10, 60,.120, 180 minutes • Asymmetry on early and delays defined a DVT

  18. AcuTect: Clinical Trails Contrast Venography • Two groups of radiologies evaluated the data • Group 1: Three independent radiologists from the imaging centers • Blinded to all other clinical data • No established reading criteria defined • Group 2: Three radiologists at one research center • Blinded to all other clinical data • Established criteria

  19. AcuTect: Clinical Trails Results • AcuTect Results • Study A = 54 (48%) • Study B = 41 (33%) • Contrast Venography Results from Group 1 • Study A = 51 (45%) • Study B = 101 (82%) • Contrast Venography Results from Group 2 • Study A = 24 (21%) • Study B = 40 (33%) • AcuTect vs Group 2 (Research Center) Agreement rate • Study A = 56-71% • Study B = 66-73%

  20. AcuTect: Comments/ Recommendations • Literature research seems limited • Can it be done before or after a V/Q lung scan? • Protocol suggest 10 and 60 minute delayed images • Digital image for contrast enhancement • Small peptides may be immunogenic • 642 observed for 3 hours • 1 patient became hypotensive from 10 to 60 minutes post dose

  21. AcuTech: Normal variants • Collateral and superficial veins • Postsurgical sites • Nonvascular locations: joints, prostheses, muscle, skin, and soft tissue • Key - If the uptake does not persist in the late images then its normal

  22. AcuTech Case Study • 29 year old male hospitalized with extensive burns presented with a 2 day history of left calf and knee pain. The suspected area was warm to the touch. • Increased persistent uptake is noted in the distal femoral, popliteal, and posterior calf vein. • Confirmed with contrast venography

More Related